Biotechnology, Latest News, Newsroom Sep 23rd Pfizer is nearly ready to resume dosing in its phase 3 hemophilia A gene therapy trial.
Biotechnology, Latest News, Newsroom Sep 14th Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
Biotechnology, Latest News, Newsroom Aug 30th Moderna, Pfizer COVID Booster appears To Be Right Around The Corner
Biotechnology, Newsroom Aug 26th Covid Vaccine Developers Pfizer And BioNTech Got Sued By Moderna For Violating MRNA Patents
